Diseases & Conditions Market Research Reports & Industry Analysis

Reports in Diseases and conditions would either cover market size and forecasting for disease treatments or for medical devices, instrumentation and durable medical equipment associated with the care for a given disease. Diseases are usually more serious; conditions more common but this terminology is not always followed. Diabetes, Hypertension and Gout are a few examples of diseases. Anemia is a condition in which one has an abnormally low number of red blood cells (RBCs). Anemia also can occur if one’s RBCs don't contain substantial hemoglobin. Hemoglobin is an iron-rich protein that assists RBCs in carrying oxygen from the lungs to the the body. One who has anemia doesn't get enough oxygen-rich blood. As a result, they may feel tired and have other symptoms. Severe or long-lasting anemia can damage the heart, brain, and other organs of the body. Very severe anemia may even cause death. varicose veins are swollen, twisted veins that you can see just under the surface of the skin. These veins usually occur in the legs, but they also can form in other parts of the body. Varicose veins are common. They usually cause few signs and symptoms. Sometimes varicose veins cause mild to moderate pain, blood clots, skin ulcers , or other problems.

Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.

...Show More ...Show Less


Diseases & Conditions Industry Research & Market Reports

  • Cancer Cachexia

    ... at a CAGR of 5.6% over the analysis period 2023-2030. Progestogens Therapeutics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.5 Billion by the end of ... Read More

  • Infection Control

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Protective Barriers, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$34.8 Billion by the end of ... Read More

  • Untreated Metastatic or Unresectable Melanoma- Pipeline Insight, 2024

    ... landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline ... Read More

  • Global Huntington’s Disease Treatment Market Forecast Report by Drug Type (Approved Drugs, Off-label Drugs) End user (Hospital Pharmacy, Drug Store & Retail Pharmacy, Online Pharmacy) Countries and Company Analysis, 2024-2032

    ... Global Huntington’s Disease Treatment Market is expected to grow beyond US$ 1,728.6 million in the year 2032, up from US$ 436.0 million in 2023, with a CAGR of 16.54 percent from 2024 to 2032. This ... Read More

  • Allergy Diagnostics

    ... at a CAGR of 10.2% over the analysis period 2023-2030. Allergy Diagnostics Assay Kits, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$4.5 Billion by the ... Read More

  • Building Panels

    ... at a CAGR of 5.7% over the analysis period 2023-2030. Residential Application, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$166.6 Billion by the end of ... Read More

  • DevOps

    ... of 17.5% over the analysis period 2023-2030. DevOps Solutions, one of the segments analyzed in the report, is expected to record a 16.4% CAGR and reach US$19.9 Billion by the end of the analysis period. ... Read More

  • Integrated Workplace Management Systems (IWMS)

    ... is expected to reach US$8.4 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. IWMS Solutions, one of the segments analyzed in the report, is expected to record a 10.3% ... Read More

  • Scoliosis Management

    ... at a CAGR of 4.1% over the analysis period 2023-2030. Thoracolumbosacral Orthosis (TLSO), one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$2.9 Billion by the end ... Read More

  • Poultry Chicken

    ... Thousand Metric Tons by 2030, growing at a CAGR of 2.8% over the analysis period 2023-2030. The U.S. Market is Estimated at 28.1 Thousand Metric Tons While China is Forecast to Grow at 4.7% CAGR ... Read More

  • Connectors

    ... of 5.8% over the analysis period 2023-2030. PCB Connectors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$32.7 Billion by the end of the analysis period. ... Read More

  • Osteoporosis Therapeutics

    ... at a CAGR of 2.8% over the analysis period 2023-2030. Bisphosphonates Drug Class, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$8.1 Billion by the end ... Read More

  • N95 Masks

    ... at a CAGR of 11.3% over the analysis period 2023-2030. Offline Distribution Channel, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$13.5 Billion by the end ... Read More

  • Healthcare Distribution

    ... at a CAGR of 13.9% over the analysis period 2023-2030. Pharmaceutical Distribution, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$2.3 Trillion by the end of ... Read More

  • Autoimmune Disease Therapeutics

    ... by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Anti-inflammatory Drug Class, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$183.0 Billion ... Read More

  • Personal Finance Software

    ... by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Web-based Software, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$941.0 Million by ... Read More

  • Protective Eyewear

    ... at a CAGR of 4.5% over the analysis period 2023-2030. Non-Prescription Protective Eyewear, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end ... Read More

  • Missiles

    ... of 4.7% over the analysis period 2023-2030. Surface-to-Surface Missiles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$63.6 Billion by the end of the analysis period. ... Read More

  • North America Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Country 2024-2032

    ... North America travel vaccines market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. ... Read More

  • Cord Blood Banking Services Market Report by Component (Cord Blood, Cord Tissue), Storage Services (Public Cord Blood Banks, Private Cord Blood Banks), Application (Cancer Disease, Diabetes, Blood Disease, Immune Disorders, Metabolic Disorders, and Others), and Region 2024-2032

    ... Region 2024-2032 The global cord blood banking services market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.2 Billion by 2032, exhibiting a growth rate (CAGR) ... Read More

  • Italy Diabetes Market Report: 2024-2032

    ... of 3.7% during 2024-2032. IMARC’s new report “Italy Diabetes Market Report: 2024-2032” provides an analytical and statistical insight into the Italy diabetes market. The report provides both current and future trends in the prevalence, demographical ... Read More

  • Deep Brain Stimulation Devices

    ... reach US$2.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Dual-Channel Deep Brain Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.0% ... Read More

  • Wearable Fitness Technology

    ... by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Smartwatches, one of the segments analyzed in the report, is expected to record a 15.0% CAGR and reach US$11.0 Billion by the ... Read More

  • High Temperature Insulation (HTI)

    ... reach US$9.2 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Ceramic Fibers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach ... Read More

  • Glucose Monitoring Devices

    ... by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Self-Monitoring Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$11.3 Billion by ... Read More

Cookie Settings